<DOC>
	<DOCNO>NCT01553474</DOCNO>
	<brief_summary>Background : - The Age-Related Eye Disease Study 2 ( AREDS 2 ) look different eye disease . Study participant provide blood saliva sample . The sample store research eye diseases . Objectives : - To collect blood saliva sample AREDS 2 research . Eligibility : - AREDS 2 research study participant . Design : - Participants provide blood saliva sample . - The sample submit personal medical information . This information collect AREDS 2 procedure .</brief_summary>
	<brief_title>Blood Saliva Sample Collection AREDS 2</brief_title>
	<detailed_description>AREDS2 multi-center , Phase III , randomize clinical trial design assess effect oral supplementation high dos macular xanthophyll ( lutein zeaxanthin ) and/or omega-3 long-chain polyunsaturated fatty acid ( LCPUFAs ) treatment age-related macular degeneration ( AMD ) , cataract moderate vision loss . In addition objective , AREDS2 study provide information clinical course , prognosis , risk factor development progression AMD cataract . Other study goal include evaluation eliminate beta-carotene and/or reduce zinc original AREDS formulation progression development AMD . AREDS2 also seek validate fundus photographic AMD scale develop AREDS . The objective protocol AREDS2 participant submit blood saliva sample AREDS2 Genetic Repository ( Fisher BioServices , Rockville , MD ) order provide material study genetic biochemical base eye disease possibly diseases .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : Participants eligible enrol AREDS2 protocol willing blood drawn saliva collect . EXCLUSION CRITERIA : Participants eligible enrolled AREDS2 willing blood drawn saliva collect .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 5, 2013</verification_date>
	<keyword>Age-Related Macular Degeneration ( AMD )</keyword>
	<keyword>Eye Diseases</keyword>
</DOC>